Is Breast-conserving Therapy Really a Good Option for BRCA1/2 Mutation Carriers?
Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. Electronic address: martin.nilsson@med.lu.se.
M P
MP
Nilsson
Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
N
N
Loman
D001943:Breast Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D006801:Humans